病毒性肺炎,尤其是腺病毒肺炎,是婴幼儿时期的常见重症,是我矿区近年儿科死亡的主要原因。几年来我们为了降低此病死亡率保护矿工子女健康,不断寻找提高治愈率的方法。自1975年1月到77年5月,对106例病毒性肺炎的住院病儿,采用了大剂量维生素丙静点为主的治疗。将此组病儿与74年未加用大剂量维生素丙的一组病儿相比较,初步从实践中检验了大剂量维生素丙静点对病毒性肺炎在退热,缩短病程、降低死亡率方面有肯定的效果。现将疗效分析报告如下: Viral pneumonia, especially adenovirus pneumonia, is a common severe illness in infancy and early childhood, a major cause of pediatric death in recent years in mine areas. In recent years, we have been looking for ways to increase the cure rate in order to reduce the mortality of the disease and protect the health of miners and children. From January 1975 to May 2017, 106 infants with viral pneumonia were treated with high-dose intravenous vitamin C intravenously. Comparing this group of sick children with a group of sick children who did not use high-dose vitamin C for 74 years, we initially tested the effect of high-dose vitamin C intravenous injection on viral pneumonia in reducing fever, shortening the course of disease and reducing mortality in practice Have a positive effect. The curative effect analysis report is as follows now: